Davenport & Co’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,782
| Closed | -$345K | – | 1002 |
|
|
2022
Q2 | $345K | Buy |
5,782
+456
| +9% | +$27.2K | ﹤0.01% | 764 |
|
|
2022
Q1 | $387K | Buy |
5,326
+1,135
| +27% | +$82.5K | ﹤0.01% | 787 |
|
|
2021
Q4 | $352K | Buy |
4,191
+56
| +1% | +$4.7K | ﹤0.01% | 834 |
|
|
2021
Q3 | $373K | Buy |
4,135
+883
| +27% | +$79.7K | ﹤0.01% | 794 |
|
|
2021
Q2 | $310K | Buy |
+3,252
| New | +$310K | ﹤0.01% | 775 |
|